Related Experiment Video
Updated: Jan 29, 2026

Biomarkers in an Animal Model for Revealing Neural, Hematologic, and Behavioral Correlates of PTSD
Published on: October 10, 2012
Correlative Biomarker Analysis of PSMA Expression on CTCs and PSMA Imaging in a Phase I Study of PSMA-Targeted
Samir Zaidi1,2,3, Phillip H Kuo4, Tiago Paiva Prudente3
1Department of Genitourinary Oncology, Memorial Sloan Kettering Cancer Center, New York, New York.
Purpose:
Prostate-specific membrane antigen (PSMA)-directed therapies provide meaningful clinical benefit in metastatic castration-resistant prostate cancer (mCRPC), yet responses remain limited, underscoring the need for additional biomarkers of PSMA expression heterogeneity. In this study, we explored the relationship between PSMA imaging and PSMA expression on circulating tumor cells (CTC) in our early-phase trial using a PSMA-targeted small molecule.
Experimental Design:
This phase I study investigated EC1169, a small molecule conjugated to a tubulysin analog warhead, and 99mTc-EC0652, a PSMA imaging agent. Part A (dose escalation) identified the recommended phase II dose. Part B (dose expansion) assessed radiographic progression-free survival (rPFS) as its primary endpoint. We enrolled and treated 103 patients with mCRPC. Most part B patients underwent 99mTc-EC0652 PSMA imaging. A CTC assay assessed PSMA-positive CTCs and their association with response and PSMA imaging.
Results:
99mTc-EC0652 single-photon emission computed tomography (SPECT) imaging demonstrated increased sensitivity for detecting bone lesions compared with standard scans (computed tomography/bone scans). Using an optimized CTC assay, we observed that patients with a decrease in PSMA+ CTCs at baseline versus C3D1 displayed a longer rPFS (8 vs. 2.9 months; P = 0.04). Importantly, patients with predominantly PSMA-positive disease on 99mTc-EC0652 imaging also harbored PSMA-negative CTCs, with a subset displaying neuroendocrine prostate cancer-like morphology.
Conclusions:
Although EC1169 showed limited activity, CTC and imaging analyses showed significant heterogeneity in PSMA expression on CTCs in patients with predominantly PSMA-positive lesions on SPECT. Our study highlights the importance of assessing both PSMA-based CTC and imaging assays in future validation trials.
Insights
Biomarkers for prostate cancer therapy are crucial. This study found that assessing both PSMA imaging and circulating tumor cells (CTCs) reveals significant PSMA expression heterogeneity, impacting treatment response.
Area of Science:
- Oncology
- Molecular Imaging
- Prostate Cancer Research
Background:
- Prostate-specific membrane antigen (PSMA) targeted therapies offer clinical benefits in metastatic castration-resistant prostate cancer (mCRPC).
- Limited response rates highlight the need for better biomarkers to understand PSMA expression heterogeneity.
Purpose of the Study:
- To explore the relationship between PSMA imaging and PSMA expression on circulating tumor cells (CTCs).
- To evaluate a PSMA-targeted small molecule and imaging agent in mCRPC patients.
Main Methods:
- Phase 1 study of EC1169 (small molecule) and 99mTc-EC0652 (PSMA imaging agent) in 103 mCRPC patients.
- Assessed PSMA-positive CTCs and their association with response and PSMA imaging via a CTC assay.
- Utilized 99mTc-EC0652 SPECT imaging for lesion detection.
Main Results:
- 99mTc-EC0652 SPECT imaging showed higher sensitivity for bone lesions than standard scans.
- A decrease in PSMA-positive CTCs correlated with longer radiographic progression-free survival (rPFS) (8.0 vs. 2.9 months).
- Patients with PSMA-positive imaging findings also had PSMA-negative CTCs, with some showing neuroendocrine prostate cancer (NEPC)-like morphology.
Conclusions:
- EC1169 demonstrated limited activity.
- Significant heterogeneity in PSMA expression on CTCs was observed, even in patients with PSMA-positive imaging.
- Combined assessment of PSMA-based CTCs and imaging is important for future mCRPC trials.
More Related Videos
11:56In vitro Method to Observe E-selectin-mediated Interactions Between Prostate Circulating Tumor Cells Derived From Patients and Human Endothelial Cells
Published on: May 15, 2014
11:26Robotics and Dynamic Image Analysis for Studies of Gene Expression in Plant Tissues
Published on: May 5, 2010
Related Concept Videos
Phase II Conjugation Reactions: Overview
Phase II Reactions: Miscellaneous Conjugation Reactions
A key example involves the conjugation of cyanide ions, which impair cellular respiration and alter hemoglobin into non-oxygen-carrying cyanmethemoglobin. To neutralize this threat, a sulfur atom from thiosulphate is transferred to the cyanide ion, catalyzed by the enzyme rhodanese, resulting in an inactive compound called thiocyanate. The production of...
Phase II Reactions: Sulfation and Conjugation with α-Amino Acids
Phase II Reactions: Glutathione Conjugation and Mercapturic Acid Formation
Several distinctive characteristics distinguish glutathione conjugation from other phase II...
Correlations
Correlation and Causation
Correlation versus Causation
If the dependent variable increases or decreases when the independent variable increases, there is a positive or negative...